Controlling the prion propensity of glutamine/asparagine-rich proteins

REFERENCES

• Liebman SW, Chernoff YO. Prions in yeast. Genetics 2012; 191:1041-72; PMID:22879407; http://dx.doi.org/10.1534/genetics.111.137760
   PubMed Web of Science ®Google Scholar
• Wickner RB, Shewmaker FP, Bateman DA, Edskes HK, Gorkovskiy A, Dayani Y, Bezsonov EE. Yeast prions: structure, biology, and prion-handling systems. Microbiol Mol Biol Rev 2015; 79:1-17; PMID:25631286; http://dx.doi.org/10.1128/MMBR.00041-14
   PubMed Web of Science ®Google Scholar
• King OD, Gitler AD, Shorter J. The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease. Brain Res 2012; 1462:61-81; PMID:22445064; http://dx.doi.org/10.1016/j.brainres.2012.01.016
   PubMed Web of Science ®Google Scholar
• Ramaswami M, Taylor JP, Parker R. Altered ribostasis: RNA-protein granules in degenerative disorders. Cell 2013; 154:727-36; PMID:23953108; http://dx.doi.org/10.1016/j.cell.2013.07.038
   PubMed Web of Science ®Google Scholar
• Cascarina SM, Ross ED. Yeast prions and human prion-like proteins: sequence features and prediction methods. Cell Mol Life Sci 2014; 71:2047-63; PMID:24390581; http://dx.doi.org/10.1007/s00018-013-1543-6
   PubMed Web of Science ®Google Scholar
• Paul KR, Hendrich CG, Waechter A, Harman MR, Ross ED. Generating new prions by targeted mutation or segment duplication. Proc Natl Acad Sci U S A 2015; 112:8584-9; PMID:26100899; http://dx.doi.org/10.1073/pnas.1501072112
   PubMed Web of Science ®Google Scholar
• Du Z. The complexity and implications of yeast prion domains. Prion 2011; 5:311-6; PMID:22156731; http://dx.doi.org/10.4161/pri.5.4.18304
   PubMed Web of Science ®Google Scholar
• Ross ED, Baxa U, Wickner RB. Scrambled Prion Domains Form Prions and Amyloid. Mol Cell Biol 2004; 24:7206-13; PMID:15282319; http://dx.doi.org/10.1128/MCB.24.16.7206-7213.2004
   PubMed Web of Science ®Google Scholar
• Ross ED, Edskes HK, Terry MJ, Wickner RB. Primary sequence independence for prion formation. Proc Natl Acad Sci USA 2005; 102:12825-30; PMID:16123127; http://dx.doi.org/10.1073/pnas.0506136102
   PubMed Web of Science ®Google Scholar
• Toombs JA, McCarty BR, Ross ED. Compositional determinants of prion formation in yeast. Mol Cell Biol 2010; 30:319-32; PMID:19884345; http://dx.doi.org/10.1128/MCB.01140-09
   PubMed Web of Science ®Google Scholar
• Toombs JA, Petri M, Paul KR, Kan GY, Ben-Hur A, Ross ED. De novo design of synthetic prion domains. Proc Natl Acad Sci U S A 2012; 109:6519-24; PMID:22474356; http://dx.doi.org/10.1073/pnas.1119366109
   PubMed Web of Science ®Google Scholar
• Gonzalez Nelson AC, Paul KR, Petri M, Flores N, Rogge RA, Cascarina SM, Ross ED. Increasing prion propensity by hydrophobic insertion. PLoS One 2014; 9:e89286; PMID:24586661; http://dx.doi.org/10.1371/journal.pone.0089286
   PubMed Web of Science ®Google Scholar
• Alberti S, Halfmann R, King O, Kapila A, Lindquist S. A Systematic Survey Identifies Prions and Illuminates Sequence Features of Prionogenic Proteins. Cell 2009; 137:146-58; PMID:19345193; http://dx.doi.org/10.1016/j.cell.2009.02.044
   PubMed Web of Science ®Google Scholar
• Halfmann R, Alberti S, Krishnan R, Lyle N, O'Donnell CW, King OD, Berger B, Pappu RV, Lindquist S. Opposing effects of glutamine and asparagine govern prion formation by intrinsically disordered proteins. Mol Cell 2011; 43:72-84; PMID:21726811; http://dx.doi.org/10.1016/j.molcel.2011.05.013
   PubMed Web of Science ®Google Scholar
• Alexandrov AI, Polyanskaya AB, Serpionov GV, Ter-Avanesyan MD, Kushnirov VV. The effects of amino acid composition of glutamine-rich domains on amyloid formation and fragmentation. PLoS ONE 2012; 7:e46458; PMID:23071575; http://dx.doi.org/10.1371/journal.pone.0046458
   PubMed Web of Science ®Google Scholar
• MacLea KS, Paul KR, Ben-Musa Z, Waechter A, Shattuck JE, Gruca M, Ross ED. Distinct amino acid compositional requirements for formation and maintenance of the [PSI(+)] prion in yeast. Mol Cell Biol 2015; 35:899-911; http://dx.doi.org/10.1128/MCB.01020-14
   PubMed Web of Science ®Google Scholar
• Osherovich LZ, Cox BS, Tuite MF, Weissman JS. Dissection and design of yeast prions. PLoS Biol 2004; 2:E86; PMID:15045026; http://dx.doi.org/10.1371/journal.pbio.0020086
   PubMed Web of Science ®Google Scholar
• Ross ED, Minton A, Wickner RB. Prion domains: sequences, structures and interactions. Nature Cell Biol 2005; 7:1039-44; PMID:16385730; http://dx.doi.org/10.1038/ncb1105-1039
   PubMed Web of Science ®Google Scholar
• Nelson R, Sawaya MR, Balbirnie M, Madsen AO, Riekel C, Grothe R, Eisenberg D. Structure of the cross-β spine of amyloid-like fibrils. Nature 2005; 435:773-8; PMID:15944695; http://dx.doi.org/10.1038/nature03680
   PubMed Web of Science ®Google Scholar
• Ahmed AB, Znassi N, Chateau MT, Kajava AV. A structure-based approach to predict predisposition to amyloidosis. Alzheimers Demen 2015; 11(6):681-90
   PubMed Web of Science ®Google Scholar
• Tartaglia GG, Pechmann S, Dobson CM, Vendruscolo M. Life on the edge: a link between gene expression levels and aggregation rates of human proteins. Trends Biochem Sci 2007; 32:204-6; PMID:17419062; http://dx.doi.org/10.1016/j.tibs.2007.03.005
   PubMed Web of Science ®Google Scholar
• Hosoda N, Kobayashi T, Uchida N, Funakoshi Y, Kikuchi Y, Hoshino S, Katada T. Translation termination factor eRF3 mediates mRNA decay through the regulation of deadenylation. J Biol Chem 2003; 278:38287-91; PMID:12923185; http://dx.doi.org/10.1074/jbc.C300300200
   PubMed Web of Science ®Google Scholar
• Li X, Rayman JB, Kandel ER, Derkatch IL. Functional role of tia1/pub1 and sup35 prion domains: directing protein synthesis machinery to the tubulin cytoskeleton. Mol Cell 2014; 55:305-18; PMID:24981173; http://dx.doi.org/10.1016/j.molcel.2014.05.027
   PubMed Web of Science ®Google Scholar
• Shewmaker F, Mull L, Nakayashiki T, Masison DC, Wickner RB. Ure2p function is enhanced by its prion domain in Saccharomyces cerevisiae. Genetics 2007; 176:1557-65; PMID:17507672; http://dx.doi.org/10.1534/genetics.107.074153
   PubMed Web of Science ®Google Scholar
• Newby GA, Lindquist S. Blessings in disguise: biological benefits of prion-like mechanisms. Trends Cell Biol 2013; 23:251-9; PMID:23485338; http://dx.doi.org/10.1016/j.tcb.2013.01.007
   PubMed Web of Science ®Google Scholar
• Liu JJ, Lindquist S. Oligopeptide-repeat expansions modulate 'protein-only' inheritance in yeast. Nature 1999; 400:573-6; PMID:10448860; http://dx.doi.org/10.1038/22919
   PubMed Web of Science ®Google Scholar
• Wadsworth JD, Hill AF, Beck JA, Collinge J. Molecular and clinical classification of human prion disease. Br Med Bull 2003; 66:241-54; PMID:14522862; http://dx.doi.org/10.1093/bmb/66.1.241
   PubMed Web of Science ®Google Scholar
• Toombs JA, Liss NM, Cobble KR, Ben-Musa Z, Ross ED. [PSI+] maintenance is dependent on the composition, not primary sequence, of the oligopeptide repeat domain. PLoS One 2011; 6:e21953; PMID:21760933; http://dx.doi.org/10.1371/journal.pone.0021953
   PubMed Web of Science ®Google Scholar
• Kajava AV. Tandem repeats in proteins: from sequence to structure. J Struct Biol 2012; 179:279-88; PMID:21884799; http://dx.doi.org/10.1016/j.jsb.2011.08.009
   PubMed Web of Science ®Google Scholar
• Katti MV, Sami-Subbu R, Ranjekar PK, Gupta VS. Amino acid repeat patterns in protein sequences: their diversity and structural-functional implications. Protein Sci 2000; 9:1203-9; PMID:10892812; http://dx.doi.org/10.1110/ps.9.6.1203
   PubMed Web of Science ®Google Scholar
• Alexandrov AI, Ter-Avanesyan MD. Could yeast prion domains originate from polyQ/N tracts? Prion 2013; 7:209-14; PMID:23764835; http://dx.doi.org/10.4161/pri.24628
   PubMed Web of Science ®Google Scholar
• Kelly JW. The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways. Curr Opin Struct Biol 1998; 8:101-6; PMID:9519302; http://dx.doi.org/10.1016/S0959-440X(98)80016-X
   PubMed Web of Science ®Google Scholar
• Maurer-Stroh S, Debulpaep M, Kuemmerer N, Lopez de la Paz M, Martins IC, Reumers J, Morris KL, Copland A, Serpell L, Serrano L, Schymkowitz JW, Rousseau F. Exploring the sequence determinants of amyloid structure using position-specific scoring matrices. Nat Meth 2010; 7:237-42; PMID:20154676; http://dx.doi.org/10.1038/nmeth.1432
   PubMed Web of Science ®Google Scholar
• Thompson MJ, Sievers SA, Karanicolas J, Ivanova MI, Baker D, Eisenberg D. The 3D profile method for identifying fibril-forming segments of proteins. Proc Natl Acad Sci U S A 2006; 103:4074-8; PMID:16537487; http://dx.doi.org/10.1073/pnas.0511295103
   PubMed Web of Science ®Google Scholar
• Chiti F, Dobson CM. Amyloid formation by globular proteins under native conditions. Nat Chem Biol 2009; 5:15-22; PMID:19088715; http://dx.doi.org/10.1038/nchembio.131
   PubMed Web of Science ®Google Scholar
• Chen B, Bruce KL, Newnam GP, Gyoneva S, Romanyuk AV, Chernoff YO. Genetic and epigenetic control of the efficiency and fidelity of cross-species prion transmission. Mol Microbiol 2010; 76:1483-99; PMID:20444092; http://dx.doi.org/10.1111/j.1365-2958.2010.07177.x
   PubMed Web of Science ®Google Scholar
• Sabate R, Rousseau F, Schymkowitz J, Ventura S. What makes a protein sequence a prion? PLoS Comput Biol 2015; 11:e1004013; PMID:25569335; http://dx.doi.org/10.1371/journal.pcbi.1004013
   PubMed Web of Science ®Google Scholar